{"id":1118,"date":"2013-02-27T11:56:51","date_gmt":"2013-02-27T16:56:51","guid":{"rendered":"https:\/\/www.bu.edu\/slone\/?page_id=1118"},"modified":"2013-03-13T16:14:37","modified_gmt":"2013-03-13T20:14:37","slug":"bufs","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/slone\/research\/studies\/bufs\/","title":{"rendered":"Boston University Fever Study (BUFS)"},"content":{"rendered":"<h3>Objectives<\/h3>\n<p>To provide valid, stable, and clinically  relevant information on the occurrence of rare but serious events among  children receiving ibuprofen suspension for fever control.<\/p>\n<h3>Methods<\/h3>\n<p>Physicians in private practice  (pediatricians and family physicians) enrolled into the study patients  with a febrile illness for whom they would normally recommend  acetaminophen or ibuprofen (available by prescription only) for the  control of fever. After obtaining written informed consent from a parent  or guardian, the physician dispensed a bottle containing either  acetaminophen or ibuprofen blindly. Four weeks after enrollment, the  parents of each enrolled child received a questionnaire by mail  inquiring as to the outcome of the illness and the occurrence of any  complications or adverse reactions to treatment. Complications (or  adverse reactions) requiring hospital admission were confirmed by review  of the relevant medical records. The safety of pediatric ibuprofen was  assessed by comparing the rates of serious complications and adverse  reactions among acetaminophen and ibuprofen treated children.<\/p>\n<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">Investigators and Study Staff<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<p>Allen A. Mitchell, M.D., Principal Investigator<br \/>\nSamuel M. Lesko, M.D., M.P.H., Co-Investigator<\/p>\n<p><\/div>\n<\/div>\n\n<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">Study Details<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<p><b>Source of Funding:<\/b><\/p>\n<p style=\"padding-left: 30px;\">McNeil Consumer Products Company<\/p>\n<p><b>Study Period:<\/b><\/p>\n<p style=\"padding-left: 30px;\">September 1990 to March 1994<\/p>\n<p><\/div>\n<\/div>\n\n<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">Publications<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<ul>\n<li>Lesko SM. The safety of ibuprofen suspension in children. Int J Clin Pract Suppl 2003;135:50-3.<\/li>\n<\/ul>\n<ul>\n<li>Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002;109:e20.<\/li>\n<\/ul>\n<ul>\n<li>Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999;104(4):e39.<\/li>\n<\/ul>\n<ul>\n<li>Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997;100:954-7.<\/li>\n<\/ul>\n<ul>\n<li>Lesko SM, Mitchell AA. Pediatric ibuprofen and leukopenia [letter to the editor]. J Am Med Assoc 1996;275:986.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Lesko SM. When a randomised controlled trial is needed to assess drug safety: the case of paediatric ibuprofen. Drug Saf 1995;13:15-24.<\/li>\n<\/ul>\n<ul>\n<li>Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. J Am Med Assoc 1995;273:929-33.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Lesko S. Can practice-based experience define the safety of pediatric ibuprofen? California Pediatrician 1992;8:55-8.<\/li>\n<\/ul>\n<p><\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>Objectives To provide valid, stable, and clinically relevant information on the occurrence of rare but serious events among children receiving ibuprofen suspension for fever control. Methods Physicians in private practice (pediatricians and family physicians) enrolled into the study patients with a febrile illness for whom they would normally recommend acetaminophen or ibuprofen (available by prescription [&hellip;]<\/p>\n","protected":false},"author":4351,"featured_media":0,"parent":37,"menu_order":68,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/pages\/1118"}],"collection":[{"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/users\/4351"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/comments?post=1118"}],"version-history":[{"count":4,"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/pages\/1118\/revisions"}],"predecessor-version":[{"id":1185,"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/pages\/1118\/revisions\/1185"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/pages\/37"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/slone\/wp-json\/wp\/v2\/media?parent=1118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}